EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CD133 Shapes Extracellular Vesicle Cargo and Angiogenic Function in Basal‐Like Triple‐Negative Breast Cancer

Mireia Gomez-Duro iD, Ptissam Bergam iD, Sara Sanchez-Redondo, Florent Dingli iD, Alix Zhou, Alain Joliot iD, Mengliang Ye iD, Marta Hergueta-Redondo, Lucas Alves Tavares iD, Damarys Loew iD, Thierry Dubois iD, Lorena Martin-Jaular iD und 3 weitere

Journal of Extracellular Vesicles · 2026-06 · 15 (6)

DOI: 10.1002/jev2.70303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 28.05.2026. Verfasst von Mireia Gomez-Duro und 14 weiteren Autor:innen. Beteiligte Einrichtung: Structure and Membrane Compartments, Institut Curie, PSL Research University, Paris, France. Hauptthemen laut MEDLINE: AC133 Antigen, Extracellular Vesicles, Triple Negative Breast Neoplasms, Neovascularization, Pathologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centre National de la Recherche Scientifique (CNRS), Institut Curie, Fondation ARC pour la Recherche sur le Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are central mediators of tumour‐stroma communication, yet the mechanisms governing their biogenesis and functional cargo remain poorly understood. Here, we identify CD133 (Prominin‐1), selectively expressed in basal‐like triple‐negative breast cancer (BL‐TNBC) cells, acts as a key organizer of EV production and cargo composition. CD133 localizes to plasma membrane protrusions and lipid rafts, where it maintains membrane architecture, promotes EV release and directs selective cargo loading, including the pro‐angiogenic factor CD105. Functionally, CD133 + EVs potently induce endothelial tubulogenesis in a CD105‐dependent manner, independently of differences in EV association or endothelial proliferation. In vivo, these EVs preferentially accumulate in the lung and liver, highlighting organ‐specific communication. Mechanistically, CD133 maintains lipid raft integrity, facilitating selective CD105 incorporation into vesicles and establishing a spatially coordinated CD133‐CD105 axis. Together, our findings define a subtype‐specific EV population whose identity and angiogenic activity are dictated by membrane organization. By linking protrusion architecture to vesicle‐mediated signalling, this study highlights CD133‐enriched EVs as potential biomarkers and therapeutic targets in aggressive BL‐TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AC133 AntigenExtracellular VesiclesTriple Negative Breast NeoplasmsNeovascularization, PathologicHumansFemaleAnimalsEndoglinCell Line, TumorMice

Stichwörter der Autor:innen

CD105 (endoglin)CD133 (Prominin‐1)angiogenesisbreast cancerextracellular vesicles

Substanzen

AC133 AntigenPROM1 protein, humanEndoglin

Autor:innen und Institutionen

  • Structure and Membrane Compartments, Institut Curie, PSL Research University, Paris, France.
  • Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • CurieCoreTech Mass Spectrometry Proteomics, Institut Curie, PSL Research University, Paris, France.
  • INSERM U932, Institut Curie Research Center, PSL Research university, Paris, France.
  • CurieCoreTech ExtracellularVesicles, Institut Curie Research Center, Paris, France.
  • Translational Research Department, CNRS UMR144 Cell Biology and Cancer, Breast Cancer Biology Group, Institut Curie - PSL Research University, Sorbonne Université, Paris, France.

ORCID-Profile: Mireia Gomez-Duro, Ptissam Bergam, Florent Dingli, Alain Joliot, Mengliang Ye, Lucas Alves Tavares, Damarys Loew, Thierry Dubois, Lorena Martin-Jaular, Hector Peinado, Graça Raposo, Gisela D'Angelo

Förderung

  • Centre National de la Recherche Scientifique (CNRS)
  • Institut Curie
  • Fondation ARC pour la Recherche sur le Cancer
  • La Ligue Contre le Cancer
  • European Union
  • EVCA Twining project
  • European Union's Horizon 2020 research and innovation programme
  • Marie Skłodowska-Curie

Zitieren

APA

Gomez-Duro, M., Bergam, P., Sanchez-Redondo, S., Dingli, F., Zhou, A., Joliot, A., Ye, M., Hergueta-Redondo, M., Tavares, L. A., Loew, D., Dubois, T., Martin-Jaular, L., Peinado, H., Raposo, G., & D'Angelo, G. (2026). CD133 Shapes Extracellular Vesicle Cargo and Angiogenic Function in Basal‐Like Triple‐Negative Breast Cancer. Journal of Extracellular Vesicles, 15(6). https://doi.org/10.1002/jev2.70303

Vancouver

Gomez-Duro M, Bergam P, Sanchez-Redondo S, Dingli F, Zhou A, Joliot A, et al. CD133 Shapes Extracellular Vesicle Cargo and Angiogenic Function in Basal‐Like Triple‐Negative Breast Cancer. Journal of Extracellular Vesicles. 2026;15(6). doi:10.1002/jev2.70303

BibTeX
@article{GomezDuro2026,
  author = {Gomez-Duro, Mireia and Bergam, Ptissam and Sanchez-Redondo, Sara and Dingli, Florent and Zhou, Alix and Joliot, Alain and Ye, Mengliang and Hergueta-Redondo, Marta and Tavares, Lucas Alves and Loew, Damarys and Dubois, Thierry and Martin-Jaular, Lorena and Peinado, Hector and Raposo, Graça and D'Angelo, Gisela},
  title = {CD133 Shapes Extracellular Vesicle Cargo and Angiogenic Function in Basal‐Like Triple‐Negative Breast Cancer},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  volume = {15},
  number = {6},
  doi = {10.1002/jev2.70303}
}
Kostenlos starten →